Pancreatitis in tigecycline Phase 3 and 4 clinical studies

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 3, 2014, Pages 773-778

  McGovern, Paul C ^a   Wible, Michele ^a   Korth Bradley, Joan M ^a   Quintana, Alvaro ^a  

^a PFIZER INC   (United States)

Author keywords

Adverse events; Furosemide; Glycylcycline

Indexed keywords

ANTIINFECTIVE AGENT; MINOCYCLINE; TIGECYCLINE;

ADULT; AGED; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PANCREATITIS; PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLINICAL TRIALS, PHASE III AS TOPIC; CLINICAL TRIALS, PHASE IV AS TOPIC; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINOCYCLINE; PANCREATITIS;

EID: 84894034464     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt427     Document Type: Article

References (13)

1. Balani AR, Grendell JH. Drug-induced pancreatitis: incidence, management and prevention. Drug Saf 2008; 31: 823-37.
2. Gilson M, Moachon L, Jeanne L et al. Acute pancreatitis related to tigecycline: case report and review of the literature. Scand J Infect Dis 2008; 40: 681-3.
3. Hung WY, Kogelman L, Volpe G et al. Tigecycline-induced acute pancreatitis: case report and literature review. Int J Antimicrob Agents 2009; 34: 486-9.
4. Mascarello M, Papa G, Arnez ZM et al. Acute necrotizing pancreatitis related to tigecycline. J Antimicrob Chemother 2012; 67: 1296-7.
5. Prot-Labarthe S, Youdaren R, Benkerrou M et al. Pediatric acute pancreatitis related to tigecycline. Pediatr Infect Dis J 2010; 29: 890-1.
6. Marshall SR. Tigecycline-induced pancreatitis. Hosp Pharm 2009; 44: 239-41.
7. Lipshitz J, Kruh J, Cheung P et al. Tigecycline-induced pancreatitis. J Clin Gastroenterol 2009; 43: 93.
8. Marot JC, Jonckheere S, Munyentwali H et al. Tigecycline-induced acute pancreatitis: about two cases and review of the literature. Acta Clin Belg 2012; 67: 229-32.
9. Tygacilw (Tigecycline) for Injection for Intravenous Use (Prescribing Information). Philadelphia, PA:Wyeth Pharmaceuticals Inc., 2013.
10. Badalov N, Baradarian R, Iswara K et al. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol 2007; 5: 648-61.
11. KadoyamaK,SakaedaT, TamonA.et al.Adverseeventprofileof tigecycline: data mining of the public version of the US Food and Drug Administration adverse event reporting system. Biol Pharm Bull 2012; 35: 967-70.
12. Okon E, Engell C, van Manen R et al. Tigecycline-related pancreatitis: a review of spontaneous adverse event reports. Pharmacotherapy 2013; 33: 63-8.
13. Elmore MF, Rogge JD. Tetracycline-inducedpancreatitis. Gastroenterology 1981; 81: 1134-6